Pfizer Secures China Rights to Obesity Drug in $495 Million Deal
Pfizer Inc. has acquired exclusive rights to commercialize an obesity therapy in China, strengthening its push into the fast-growing weight…
Pfizer Inc. has acquired exclusive rights to commercialize an obesity therapy in China, strengthening its push into the fast-growing weight…
Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in New York…
Pfizer on Tuesday hailed a study of a weight-loss-drug candidate while forecasting a profit decline due to the impact of…
Source: Bloomberg, 4:40 www.bloomberg.com #Stock #Movers #Pfizer #Merck #Pepsi #Podcast
Albert Bourla, CEO of Pfizer, speaking on Squawk on the Street at the World Economic Forum in Davos, Switzerland on…
Pfizer Inc. (NYSE:PFE) is included among Dividend Contenders List: Top 20 Stocks. Pfizer to Exit ViiV Healthcare as GSK and…
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey |…
All three of these companies are well established, with solid growth prospects. Each faces some struggles, but all are paying…
Pfizer CEO Albert Bourla says the company is looking for “superior” results on weight-loss drugs. Speaking with Katie Greifeld at…
Pfizer Inc. (NYSE:PFE) is one of the best high volume stocks to buy right now. On December 16, Bank of…